Literature DB >> 29519268

Hepatocyte Wnts Are Dispensable During Diethylnitrosamine and Carbon Tetrachloride-Induced Injury and Hepatocellular Cancer.

Morgan Preziosi1, Minakshi Poddar1, Sucha Singh1, Satdarshan P Monga1.   

Abstract

Activation of the Wnt/β-catenin signaling is reported in large subsets of hepatocellular carcinoma (HCC). Upregulation of Wnt genes is one contributing mechanism. In the current study, we sought to address the role of hepatocyte-derived Wnts in a model of hepatic injury, fibrosis, and carcinogenesis. We subjected hepatocyte-specific Wntless knockout mice (HP-KO), unable to secrete Wnts from hepatocytes, and littermate controls (HP-CON) to diethylnitrosamine and carbon tetrachloride (DEN/CCl4) and harvested at 3, 5, and 6 months for histological and molecular analysis. Analysis at 5 months displayed increased hepatic expression of several Wnts and upregulation of some, but not all, β-catenin targets, without mutations in Ctnnb1. At 5 months, HP-CON and HP-KO had comparable tumor burden and injury; however, HP-KO uniquely showed small CK19+ foci within tumors. At 6 months, both groups were moribund with comparable tumor burden and CK19 positivity. While HCC histology was indistinguishable between the groups, HP-KO exhibited increased active β-catenin and decreased c-Myc, Brd4, E-cadherin, and others. Hepatic injury, inflammation, and fibrosis were also indistinguishable at 3 months between both groups. Thus, lack of Wnt secretion from hepatocytes did not affect overall injury, fibrosis, or HCC burden, although there were protein expression differences in the tumors occurring in the two groups.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29519268      PMCID: PMC6190118          DOI: 10.3727/105221618X15205148413587

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  48 in total

1.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc Pharmacol       Date:  2014-09-02

2.  Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.

Authors:  Diego F Calvisi; Elizabeth A Conner; Sara Ladu; Eric R Lemmer; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2005-04-08       Impact factor: 25.083

3.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

Authors:  X Zhang; J P Gaspard; D C Chung
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

4.  Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells.

Authors:  Carla Bänziger; Davide Soldini; Corina Schütt; Peder Zipperlen; George Hausmann; Konrad Basler
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

5.  Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.

Authors:  Jung Il Lee; Jin-Woo Lee; Joon Mee Kim; Ja Kyung Kim; Hyun Jung Chung; Young Soo Kim
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

6.  New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.

Authors:  Axelle Cadoret; Christine Ovejero; Benoit Terris; Evelyne Souil; Laurence Lévy; Wouter H Lamers; Jan Kitajewski; Axel Kahn; Christine Perret
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

7.  Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.

Authors:  Christine Ovejero; Catherine Cavard; Axel Périanin; Theodorus Hakvoort; Jacqueline Vermeulen; Cécile Godard; Monique Fabre; Philippe Chafey; Kazuo Suzuki; Béatrice Romagnolo; Satoshi Yamagoe; Christine Perret
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

8.  Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.

Authors:  Emilia Fransvea; Umberto Angelotti; Salvatore Antonaci; Gianluigi Giannelli
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

9.  Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.

Authors:  Gong-Quan Li; Wen-Zhi Guo; Yi Zhang; Jing-Jing Seng; Hua-Peng Zhang; Xiu-Xian Ma; Gong Zhang; Jie Li; Bing Yan; Hong-Wei Tang; Shan-Shan Li; Li-Dong Wang; Shui-Jun Zhang
Journal:  Oncotarget       Date:  2016-01-19

10.  Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.

Authors:  Gillian Hale; Xinxin Liu; Junjie Hu; Zhong Xu; Li Che; David Solomon; Christos Tsokos; Nafis Shafizadeh; Xin Chen; Ryan Gill; Sanjay Kakar
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

View more
  5 in total

1.  Elimination of Wnt Secretion From Stellate Cells Is Dispensable for Zonation and Development of Liver Fibrosis Following Hepatobiliary Injury.

Authors:  Rong Zhang; Alexander T Kikuchi; Toshimasa Nakao; Jacquelyn O Russell; Morgan E Preziosi; Minakshi Poddar; Sucha Singh; Aaron W Bell; Steven G England; Satdarshan P Monga
Journal:  Gene Expr       Date:  2018-09-20

2.  Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer.

Authors:  Satdarshan P Monga
Journal:  Gene Expr       Date:  2020-06-05

3.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc       Date:  2021-08

4.  Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.

Authors:  Elisabeth M Haberl; Rebekka Pohl; Lisa Rein-Fischboeck; Susanne Feder; Christopher J Sinal; Astrid Bruckmann; Marcus Hoering; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

5.  Functional compensation precedes recovery of tissue mass following acute liver injury.

Authors:  Chad M Walesky; Kellie E Kolb; Carolyn L Winston; Jake Henderson; Benjamin Kruft; Ira Fleming; Sungjin Ko; Satdarshan P Monga; Florian Mueller; Udayan Apte; Alex K Shalek; Wolfram Goessling
Journal:  Nat Commun       Date:  2020-11-19       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.